PER2 and cancer: In the meantime, cancer cells are capable of developing drug resistance to oxaliplatin by strengthening the ability to repair DNA adducts.22 Importantly, compared with vehicle or scramble OSCC cells, we found that overexpression of PER2 resulted in a significant increase of DNA damage and an obvious decrease of DNA adducts repair (Figure3a,b).